trending Market Intelligence /marketintelligence/en/news-insights/trending/5_LZodu_bKO2PCe_41tK7g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Athyrium, Neuberger Berman close healthcare fund at $2.03B


Banking Essentials Newsletter, January edition - part 2

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Athyrium, Neuberger Berman close healthcare fund at $2.03B

Athyrium Capital Management LP and Neuberger Berman Group LLC have closed Athyrium Opportunities Fund III at approximately $2.03 billion.

The fund will be used to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The fund invests across the healthcare sector, including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.

NB Alternatives Advisers LLC acts as a sub-adviser to the fund.